FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308953086> ?p ?o ?g. }

• W4308953086 endingPage "56" @default.
• W4308953086 startingPage "42" @default.
• W4308953086 abstract "Evidence suggests that the anti-inflammatory nucleoside adenosine can shape immune responses by shifting the regulatory (Treg )/helper (Th17) T-cell balance in favour of Treg . Since this observation is based on in vivo and in vitro studies mostly confined to murine models, we comprehensively analysed effects of adenosine on human T-cells. Proliferation, phenotype and cytokine production of stimulated T-cells were assessed by flow cytometry, multiplex assay and ELISA, gene expression profiling was determined by microarray. We found that the pan-adenosine agonist 5'-N-ethylcarboxamidoadenosine (NECA) skews human CD3+ T-cell responses towards non-inflammatory Th17 cells. Addition of NECA during T-cell activation increased the development of IL-17+ cells with a CD4+ RORγt+ phenotype and enhanced CD161 and CD196 surface expression. Remarkably, these Th17 cells displayed non-inflammatory cytokine and gene expression profiles including reduced Th1/Th17 transdifferentiation, a stem cell-like molecular signature and induced surface expression of the adenosine-producing ectoenzymes CD39 and CD73. Thus, T-cells cultured under Th17-inducing conditions together with NECA were capable of suppressing responder T-cells. Finally, genome-wide gene expression profiling revealed metabolic quiescence previously associated with non-pathogenic Th17 cells in response to adenosine signalling. Our data suggest that adenosine induces non-inflammatory Th17 cells in human T-cell differentiation, potentially through regulation of metabolic pathways." @default.
• W4308953086 created "2022-11-20" @default.
• W4308953086 creator A5001778958 @default.
• W4308953086 creator A5015465551 @default.
• W4308953086 creator A5046764994 @default.
• W4308953086 creator A5049242773 @default.
• W4308953086 creator A5060532195 @default.
• W4308953086 creator A5065859286 @default.
• W4308953086 creator A5072688181 @default.
• W4308953086 creator A5075094457 @default.
• W4308953086 date "2022-11-23" @default.
• W4308953086 modified "2023-10-12" @default.
• W4308953086 title "Adenosine signalling in T‐cell activation favours development of <scp>IL</scp>‐17 positive cells with suppressive properties" @default.
• W4308953086 cites W1483815179 @default.
• W4308953086 cites W1507917955 @default.
• W4308953086 cites W1549250486 @default.
• W4308953086 cites W161060649 @default.
• W4308953086 cites W1827430542 @default.
• W4308953086 cites W1928151495 @default.
• W4308953086 cites W1973603971 @default.
• W4308953086 cites W1976355501 @default.
• W4308953086 cites W1977187462 @default.
• W4308953086 cites W1984390733 @default.
• W4308953086 cites W1986072281 @default.
• W4308953086 cites W1986925527 @default.
• W4308953086 cites W1995391551 @default.
• W4308953086 cites W1998895238 @default.
• W4308953086 cites W2001776200 @default.
• W4308953086 cites W2009675211 @default.
• W4308953086 cites W2015347941 @default.
• W4308953086 cites W2016992811 @default.
• W4308953086 cites W2017893786 @default.
• W4308953086 cites W2021340905 @default.
• W4308953086 cites W2025492877 @default.
• W4308953086 cites W2043291701 @default.
• W4308953086 cites W2046039057 @default.
• W4308953086 cites W2047677831 @default.
• W4308953086 cites W2060625236 @default.
• W4308953086 cites W2065187811 @default.
• W4308953086 cites W2067885308 @default.
• W4308953086 cites W2067893695 @default.
• W4308953086 cites W2073549523 @default.
• W4308953086 cites W2077786296 @default.
• W4308953086 cites W2086264253 @default.
• W4308953086 cites W2086556660 @default.
• W4308953086 cites W2089205256 @default.
• W4308953086 cites W2091041420 @default.
• W4308953086 cites W2092182665 @default.
• W4308953086 cites W2092975931 @default.
• W4308953086 cites W2100323431 @default.
• W4308953086 cites W2102158172 @default.
• W4308953086 cites W2103119361 @default.
• W4308953086 cites W2103984309 @default.
• W4308953086 cites W2107207706 @default.
• W4308953086 cites W2112837750 @default.
• W4308953086 cites W2112926941 @default.
• W4308953086 cites W2125075553 @default.
• W4308953086 cites W2130229601 @default.
• W4308953086 cites W2133408256 @default.
• W4308953086 cites W2134053452 @default.
• W4308953086 cites W2137161025 @default.
• W4308953086 cites W2138941083 @default.
• W4308953086 cites W2140184624 @default.
• W4308953086 cites W2142721940 @default.
• W4308953086 cites W2144288685 @default.
• W4308953086 cites W2144796561 @default.
• W4308953086 cites W2144991587 @default.
• W4308953086 cites W2146718841 @default.
• W4308953086 cites W2147960116 @default.
• W4308953086 cites W2155779547 @default.
• W4308953086 cites W2158614641 @default.
• W4308953086 cites W2162873738 @default.
• W4308953086 cites W2167751983 @default.
• W4308953086 cites W2168634451 @default.
• W4308953086 cites W2168695055 @default.
• W4308953086 cites W2178538398 @default.
• W4308953086 cites W2209349785 @default.
• W4308953086 cites W2214074259 @default.
• W4308953086 cites W2281438908 @default.
• W4308953086 cites W2308927830 @default.
• W4308953086 cites W2395579671 @default.
• W4308953086 cites W2396034350 @default.
• W4308953086 cites W2442011120 @default.
• W4308953086 cites W2464468902 @default.
• W4308953086 cites W2575481614 @default.
• W4308953086 cites W2592935721 @default.
• W4308953086 cites W2606873509 @default.
• W4308953086 cites W2606900167 @default.
• W4308953086 cites W2624726675 @default.
• W4308953086 cites W2755844015 @default.
• W4308953086 cites W2768663525 @default.
• W4308953086 cites W2791090002 @default.
• W4308953086 cites W2792797672 @default.
• W4308953086 cites W2801380938 @default.
• W4308953086 cites W2884384057 @default.
• W4308953086 cites W2890228312 @default.
• W4308953086 cites W2905426112 @default.
• W4308953086 cites W2947747173 @default.

• next